Concord Medical Services
3 hedge funds and large institutions have $312K invested in Concord Medical Services in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.06% less ownership
Funds ownership: 0.42% → 0.36% (-0.06%)
44% less capital invested
Capital invested by funds: $558K → $312K (-$246K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$61.1K |
CCM Hedge Fund Activity: Q4 2021 in Review
3 of the 6,520 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q4 2021, worth a combined $312K — down 44% from $558K a quarter earlier.
Fund positioning in CCM was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $1.36K. The largest seller was Renaissance Technologies, cutting an estimated $61.1K.
- 3 institutional investors held Concord Medical Services (CCM) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $312K of Concord Medical Services stock for Q4 2021, down 44% quarter-over-quarter.
- 0 funds opened new Concord Medical Services positions in Q4 2021 and 0 closed out.
- The largest Concord Medical Services buyer in Q4 2021 was UBS Group, an estimated $1.36K added.
- The largest Concord Medical Services seller in Q4 2021 was Renaissance Technologies, an estimated $61.1K sold.
Based on aggregated 13F filings for Q4 2021.